Impact of inherited thrombophilia on venous thromboembolism in children: A systematic review and meta-analysis of observational studies

Circulation

Volumn 118, Issue 13, 2008, Pages 1373-1382

  Young, Guy ^a   Albisetti, Manuela ^b   Bonduel, Mariana ^c   Brandao, Leonardo ^d   Chan, Anthony ^e   Friedrichs, Frauke ^f   Goldenberg, Neil A ^g   Grabowski, Eric ^h   Heller, Christine ⁱ   Journeycake, Janna ^j   Kenet, Gili ^k   Krümpel, Anne ^l   Kurnik, Karin ^m   Lubetsky, Aaron ^k   Male, Christoph ⁿ   Manco Johnson, Marilyn ^g   Mathew, Prasad ^o   Monagle, Paul ^p   Van Ommen, Heleen ^q   Simioni, Paolo ^r   Svirin, Pavel ^s   Tormene, Daniela ^r   Nowak Göttl, Ulrike ^l   more..

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g Children's Hospital Colorado   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k SHEBA MEDICAL CENTER   (Israel)

^l UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^m LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁿ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^o UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^p ROYAL CHILDREN'S HOSPITAL   (Australia)

^q EMMA CHILDREN S HOSPITAL   (Netherlands)

^r UNIVERSITY OF PADOVA   (Italy)

^s PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

more..

Author keywords

Meta analysis; Pediatrics; Recurrence; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; LIPOPROTEIN A; PROTHROMBIN;

ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; GENETIC TRAIT; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RECURRENT DISEASE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; CHILD; GENETIC PREDISPOSITION; GENETICS;

CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 54049120183     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.789008     Document Type: Review

References (125)

1. Goldenberg N, Bernard TJ. Venous thromboembolism in children. Pediatr Clin N Am. 2008;55:305-322.
2. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995;74: 415-425.
3. Athale UH, Chan AK. Thromboembolic complications in pediatric hematologic malignancies. Semin Thromb Hemost. 2007;33:416-426.
4. Journeycake JM, Buchanan GR. Thrombotic complications of central venous catheters in children. Cur Opin Hematol. 2003;10:369-374.
5. Newall F, Wallace T, Crock C, Campbell J, Savoia H, Barnes C, Monagle P. Venous thromboembolic disease: a single-centre case series study. J Paediatr Child Health. 2006;42:803-807.
6. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96:939-943.
7. Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed. 1997;76:F163-F167.
8. Revel-Vilk S, Sharathkumar A, Massicotte P, Marzinotto V, Daneman A, Dix D, Chan A. Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. J Thromb Haemost. 2004;2:42-46.
9. Journeycake J, Eshelman D, Buchanan GR. Post-thrombotic syndrome is uncommon in childhood cancer survivors. J Pediatr. 2006;148: 275-277.
10. Van Ommen CH, Ottenkamp J, Lam J, Hirasing RA, Heijmans HS, Peters M. The risk of postthrombotic syndrome in children with congenital heart disease. J Pediatr. 2002;141:582-586.
11. Kuhle S, Koloshuk B, Marzinotto V, Adams M, Bauman M, Massicotte P, Andrew M, Chan A, Abdolell M, Mitchell L. A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb Res. 2003; 111:227-233.
12. Monagle P, Adams M, Mahoney M, Ali K, Barnard D, Bernstein M, Brisson L, David M, Desai S, Scully MF, Halton J, Israels S, Jardine L, Leaker M, McCusker P, Silvia M, Wu J, Anderson R, Andrew M, Massicotte MP. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res. 2000;47:763-766.
13. van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr. 2001;139:676-681.
14. Kuhle S, Massicotte P, Chan A, Adams M, Abdolell M, de Veber G, Mitchell L. Systemic thromboembolism in children: data from the 1-800-NO-CLOTS Consultation Service. Thromb Haemost. 2004;92: 722-728.
15. Male C, Mitchell L, Julian J, Vegh P, Joshua P, Adams M, David M, Andrew ME. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood. 2001;97:844-849.
16. Levy DM, Massicotte MP, Harvey E, Hebert D, Silverman ED. Thromboembolism in paediatric lupus patients. Lupus. 2003;12:741-746.
17. Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006;55:850-855.
18. Günes AM, Baytan B, Günay U. The influence of risk factors in promoting thrombosis during childhood: the role of acquired factors. Pediatr Hematol Oncol. 2006;23:399-410.
19. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993;90:1004-1008.
20. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
21. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
22. Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost. 1997;78:297-301.
23. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol. 1999;19:511-518.
24. 506 carriers in relationship to the presence or absence of juvenile venous thromboembolism. Arterioscler Thromb Vasc Biol. 1999;19:276-280.
25. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1-7.
26. van den Belt AG, Sanson BJ, Simioni P, Prandoni P, Buller HR, Girolami A, Prins MH. Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med. 1997;157: 2227-2232.
27. Sanson BJ, Simioni P, Tormene D, Moia M, Friederich PW, Huisman MV, Prandoni P, Bura A, Rejto L, Wells P, Mannucci PM, Girolami A, Büller HR, Prins MH. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood. 1999;94:3702-3706.
28. Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, Gavasso S, Huisman MV, Büller HR, Wouter ten Cate J, Girolami A, Prins MH. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost. 1999;81:198-202.
29. Sofi F, Marcucci R, Abbate R, Gensini GF, Prisco D. Lipoprotein(a) and venous thromboembolism in adults: a meta-analysis. Am J Med. 2007; 120:728-733.
30. Rees DC. The population genetics of factor V Leiden (Arg 506 Gln). Br J Haematol. 1996;95:579-586.
31. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79:706-708.
32. Pepe G, Rickards O, Vanegas OC, Brunelli T, Gori AM, Giusti B, Attanasio M, Prisco D, Gensini GF, Abbate R. Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost. 1997; 77:329-331.
33. Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics. 1995;96:291-294.
34. Nowak-Göttl U, Koch HG, Aschka I, Kohlhase B, Vielhaber H, Kuriemann G, Oleszcuk-Raschke K, Kehl HG, Jürgens H, Schneppenheim R. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol. 1996;92:992-998.
35. Ashka I, Aumann V, Bergmann F, Budde U, Eberl W, Eckhof-Donovan S, Krey S, Nowak-Göttl U, Schobess R, Sutor AH, Wendisch J, Schneppenheim R. Prevalence of factor V Leiden in children with thromboembolism. Eur J Pediatr. 1996;155:1009-1014.
36. Gürgey A, Mesci L, Renda Y, Olcay L, Kocak N, Erdem G. Factor V Q 506 mutation in children with thrombosis. Am J Hematol. 1996;53: 37-39.
37. Sifontes MT, Nuss R, Jacobson LJ, Griffin JH, Manco-Johnson MJ. Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr. 1996;128:324-328.
38. Uttenreuther-Fischer MM, Vetter B, Hellmann C, Otting U, Ziemer S, Hausdorf G, Gaedicke G, Kulozik AE. Paediatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr. 1997;156:277-281.
39. Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson LJ, Manco-Johnson MJ. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol. 1997;96:484-489.
40. Toumi NH, Khaldi F, Ben Becheur S, Hammou A, Bouttiére B, Sampol J, Boukef K. Thrombosis in congenital deficiencies of AT III, protein C or protein S: a study of 44 children. Hematol Cell Ther. 1997;39: 295-299.
41. Nowak-Göttl U, Dübbers A, Kececioglu D, Koch HG, Kotthoff S, Runde J, Vielhaber H. Factor V Leiden, protein C, and lipoprotein(a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr. 1997;131:608-612.
42. Seixas CA, Hessel G, Ribeiro CC, Arruda VR, Annichino-Bizzacchi JM. Factor V Leiden is not common in children with portal vein thrombosis. Thromb Haemost. 1997;77:1297-1298.
43. Fabri D, Belangero VM, Annichino-Bizzacchi JM, Arruda VR. Inherited risk factors for thrombophilia in children with nephrotic syndrome. Eur J Pediatr. 1998;157:939-942.
44. Sifontes MT, Nuss R, Hunger SP, Waters J, Jacobsen LJ, Manco-Johnson M. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis. Am J Hematol. 1998;57:29-32.
45. deVeber G, Monagle P, Chan A, MacGregor D, Curtis R, Lee S, Vegh P, Adams M, Marzinotto V, Leaker M, Massicotte P, Lillicrap D, Andrew M. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol. 1998;55:1539-1543.
46. Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr. 1998;133:777-781.
47. Vielhaber H, Ehrenforth S, Koch HG, Scharrer I, van der Werf N, Nowak-Göttl U. Cerebral venous thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophilia. Eur J Pediatr. 1998;157:555-560.
48. Knöfler R, Siegert E, Lauterbach I, Taut-Sack H, Siegert G, Gehrisch S, Müller D, Rupprecht E, Kabus M. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy: impact of central venous lines. Eur J Pediatr. 1999;158(suppl 3):S147-S150.
49. Ehrenforth S, Junker R, Koch HG, Kreuz W, Münchow N, Scharrer I, Nowak-Göttl U. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood: Childhood Thrombophilia Study Group. Eur J Pediatr. 1999;158:S97-S104.
50. Schobess R, Junker R, Auberger K, Münchow N, Burdach S, Nowak-Göttl U. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis: evidence of an age-dependent thrombotic onset in carriers of the factor V G1691A and prothrombin G20210A mutation. Eur J Pediatr. 1999;158:S105-S108.
51. Münchow N, Kosch A, Schobess R, Junker R, Auberger K, Nowak-Göttl U. Role of genetic prothrombotic risk factors in childhood caval vein thrombosis. Eur J Pediatr. 1999;158(suppl 3)S109-S112.
52. Nowak-Göttl U, Junker R, Hartmeier M, Koch HG, Münchow N, Assmann G, von Eckardstein A. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation. 1999;100:743-748.
53. Nowak-Göttl U, Wermes C, Junker R, Koch HG, Schobess R, Fleischhack G, Schwabe D, Ehrenforth S. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood. 1999;93:1595-1599.
54. Bonduel M, Sciuccati G, Hepner M, Torres AF, Pieroni G, Frontroth JP. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. Arch Neurol. 1999;56:967-971.
55. Heller C, Becker S, Scharrer I, Kreuz W. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr. 1999;158(suppl 3):S117-S121.
56. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single centre. Arch Dis Child. 1999;81:176-178.
57. Salonvaara M, Riikonen P, Kekomäki R, Heinonen K. Clinically symptomatic central venous catheter-related deep venous thrombosis in newborns. Acta Paediatr. 1999;88:642-646.
58. Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol. 1999; 19:2568-2572.
59. Heller C, Schobess R, Kurnik K, Junker R, Günther G, Kreuz W, Nowak-Göttl U. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors: a multicentre case-control study: for the Childhood Thrombophilia Group. Br J Haematol. 2000;111: 534-539.
60. Kosch A, Junker R, Kurnik K, Schobess R, Günther G, Koch HG, Nowak-Göttl U. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res. 2000;99:531-537.
61. Kuhle S, Lane DA, Jochmanns K, Male C, Quehenberger P, Lechner K, Pabinger I. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. Thromb Haemost. 2001;86: 1007-1011.
62. Bonduel M, Hepner M, Sciuccati G, Torres AF, Pieroni G, Frontroth JP. Prothrombotic abnormalities in children with venous thromboembolism. J Pediatr Hematol Oncol. 2000;22:66-672.
63. Nowak-Göttl U, Junker R, Kreuz W, von Eckardstein A, Kosch A, Nohe N, Schobess R, Ehrenforth S, for the Childhood Thrombophilia Study Group. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood. 2001;97:858-862.
64. De Veber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald AE. Gillett J, Meaney B, Shevell M, Sinclair DB, Yager J. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-423.
65. Bonduel M, Hepner M, Sciuccati G, Pieroni G, Feliú-Torres A. Mardaraz C, Frontroth JP. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism. Thromb Haemost. 2002;87:972-977.
66. Atalay S, Akar N, Tutar HE, Yilmaz E. Factor V 1691 G-A mutation in children with intracardiac thrombosis: a prospective study. Acta Paediatr. 2002;91:168-171.
67. Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost. 2003;1:915-921.
68. Bonduel M, Sciuccati G, Hepner M, Pieroni G, Torres AF, Mardaraz C, Frontroth JP. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol. 2003;73: 81-86.
69. Van Ommen CH, Heijboer H, van den Dool EJ, Hutten BA, Peters M. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost. 2003;1:2516-2522.
70. Lee ACW, Li CH, Szeto SC, Ma ES. Symptomatic venous thromboembolism in Hong Kong Chinese children. Hong Kong Med J. 2003;9: 259-262.
71. Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD. Abshire T, Nugent DJ. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost. 2003;1:958-962.
72. Atasay B, Arsan S, Günlemez A, Kemhali S, Akar N. Factor V Leiden and prothrombin gene 20210A variant in neonatal thromboembolism and in healthy neonates and adults: a study in a single center. Pediatr Hematol Oncol. 2003;20:627-634.
73. Heller C, Heinecke A, Junker R, Knöfler R, Kosch A, Kurnik K, Schobess R, von Eckardstein A, Sträter R, Zieger B, Nowak-Göttl U. Cerebral venous thrombosis in children: a multifactorial origin. Circulation. 2003;108:1362-1367.
74. El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Sonoon MA, A-Kadar H. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study. Ann Hematol. 2004;83:712-715.
75. Levy ML, Granville RC, Hart D, Meltzer H. Deep venous thrombosis in children and adolescents. J Neurosurg. 2004;101:32-37.
76. Gürgey A, Balta G, Gumruk F, Altay C. Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis. Blood Coagul Fibrinol. 2004;15:657-662.
77. Pinto RB, Silveira TR, Bandinelli E, Röhsig L. Portal vein thrombosis in children and adolescents: me low prevalence of hereditary thrombophilic disorders. J Pediatr Surg. 2004;39:1356-1361.
78. Kenet G, Waldman D, Lubetsky A, Kornbrut N, Khalil A, Koren A, Wolach B, Fattal A, Kapelushnik J, Tamary H, Yacobovitch J, Raveh E, Revel-Vilk S, Toren A, Brenner B. Paediatric cerebral sinus veil thrombosis: a multi-center, case-controlled study. Thromb Haemost. 2004;92: 713-718.
79. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ, for the Mountain States Regional Thrombophilia Group. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med. 2004;351:1081-1088.
80. Kosch A, Kuwertz-Bröking E, Heller C, Kurnik K, Schobess R, Nowak-Göttl U. Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood. 2004;104:1356-1360.
81. Ören H, Devecioglu O, Ertem M, Vergin C, Kavakli K, Meral A, Canatan D, Toksoy H, Yildiz I, Küreci E, Özgen Ü, Öniz H, Gürgey A. Analysis of pediatric thrombosis patients in Turkey. Pediatr Hematol Oncol. 2004;21:573-583.
82. Rask O, Berntorp E, Ljung R. Risk factors for venous thrombosis in Swedish children and adolescents. Acta Paediatr. 2005;94:717-722.
83. Gupta PK, Ahmed RP, Bhattacharyya M, Kannan M, Biswas A, Kalra V, Saxena R. Protein C system defects in Indian children with thrombosis. Ann Hematol. 2005;84:85-88.
84. Sébire G, Tabarki B, Saunders DE, Leroy I, Liesner R, Saint-Martin C, Husson B, Williams AN, Wade A, Kirkham FJ. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005;128:477-489.
85. Ünal S, Varan A, Yalcin B, Büyükpamukcu M, Gürgey A. Evaluation of thrombotic children with malignancy. Ann Hematol. 2005;84:395-399.
86. Marks SD, Massicotte P, Steele BT, Matsell DG, Filler G, Shah PS, Perlman M, Rosenblum ND, Shah VS. Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders. J Pediatr. 2005;146:811-816.
87. Gonzalez BE, Teruya J, Mahoney DH Jr, Hulten KG, Edwards R, Lamberth LB, Hammerman WA, Mason EO Jr, Kaplan SL. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006;117:1673-1679.
88. Raffini LJ, Raybagkar D, Blumenstein MS, Rubenstein RC, Manno CS. Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital. J Pediatr. 2006;148:659-664.
89. Bonduel M, Sciuccati G, Hepner M, Pieroni G, Torres AF, Frontroth JP, Tenembaum S. Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registry. Acta Haematol. 2006;115: 180-185.
90. Morag I, Epelman M, Daneman A, Moineddin R, Parvez B, Shechter T, Hellmann J. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr. 2006;148:735-739.
91. Brandão LR, Williams S, Kahr WH, Ryan C, Temple M, Chan AK. Exercise-induced deep vein thrombosis of the upper extremity, 2: a case series in children. Acta Haematol. 2006;115:214-220.
92. Tavil B, Ozyurek E, Gumruk F, Cetin M, Gurgey A. Antiphospholipid antibodies in Turkish children with thrombosis. Blood Coagul Fibrinol. 2007;18:347-352.
93. Kreuz W, Stoll M, Junker R, Heinecke A, Schobess R, Kurnik K, Kelsch R, Nowak-Göttl U. Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study. Arterioscler Thromb Vasc Biol. 2006;26:1901-1906.
94. Sharma S, Kumar SI, Poddar U, Yaachha SK, Aggarwal R. Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India. Indian J Gastroenterol. 2006;25: 236-239.
95. Komitopoulo A, Platokouki H, Kapsimali Z, Moschovi M, Kattamis A. Mutation and polymorphisms in genes affecting haemostasis components in children with thromboembolic events. Pathophysiol Haemost Thromb. 2006;35:392-397.
96. Winyard PJD, Bharucha T, de Bruyn R, Dillon MJ, van't Hoff W, Trompeter RS, Liesner R, Wade A, Rees L. Perinatal renal venous thrombosis: presenting renal length predicts outcome. Arch Dis Child Fetal Neonatal Ed. 2006;91:F273-F278.
97. Tormene D, Gavasso S, Rossetto V, Simioni P. Thrombosis and thrombophilia in children: a systematic review. Semin Thromb Hemost. 2006; 32:724-728.
98. Gentilomo C, Franzoi M, Laverda AM, Suppiej A, Battistella PA, Simioni P. Cerebral sinovenous thrombosis in children: thrombophilia and clinical outcome. Thromb Res. 2008;121:589-591.
99. Albisetti M, Moeller A, Waldvogel K, Bernet-Buettiker V, Cannizzaro V, Anagnostopoulos A, Balmer C, Schmugge M. Congenital prothrombotic disorders in children with peripheral venous and arterial thromboses. Acta Haematol. 2007;117:149-155.
100. Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier C, Heller C, Knöfler R, Schobess R, Zieger B, Sébire G, Nowak-Göttl U. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 2007;6: 595-603.
101. Özyurek E, Balta G, Degerliyurt A, Parlak H, Aysun S, Gürgey A. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis. Clin Appl Thromb Hemost. 2007;13: 154-160.
102. Tormene D, Simioni S, Prandoni P, Franz F, Zerbinati P, Tognin G, Girolami A. The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood. 2002;100:2403-2405.
103. Sass AE, Neufeld EJ. Risk factors for thromboembolism teens: when should I test? Cur Opin Pediatr. 2002;14:370-378.
104. Wiliams MD, Chalmers E, Gibson BES. Guideline: the investigation and management of neonatal haemostasis and thrombosis. Br J Haematol. 2002;119:295-309.
105. Ruud E, Holmström H, Brosstad F, Wesenberg F. Diagnostic value of family histories of thrombosis to identify children with thrombophilia. Pediatr Hematol Oncol. 2005;22:453-462.
106. Johal SC, Garg BP, Heiny ME, LS, Saha C, Walsh LE, Golomb MR. Family history is a poor screen for prothrombotic genes in children with stroke. J Pediatr. 2006;148:68-71.
107. Dietrich JE, Hertweck SP, Perlman SE. Efficacy of familial history in determining thrombophilia risk. J Pediatr Adolesc Gynecol. 2007;20: 221-224.
108. Gürgey A, Asian D. Outcome of non-catheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol/Oncol. 2001;23:159-164.
109. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:W163-W194.
110. Monagle P, Chan A, Chalmers E, Michelson AD. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:S645-S687.
111. Mayer D. Essential Evidence-Based Medicine. New York, NY: Cambridge University Press; 2004:347-360.
112. Kirkwood BR, Sterne JAC. Medical Statistics. 2nd ed. Boston, Mass: Blackwell Science; 2003:180-387.
113. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-560.
114. Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25:3443-3457.
115. Gürgey A, Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr. 1997;39:313-315.
116. Gürgey A, Hicsönmez G, Parlak H, Günay B, Celiker A. The prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol. 1998;59:179-180.
117. Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, Donati MB. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108:2216-2222.
118. Haywood S, Liesner R, Pindora S, Ganesan V. Thrombophilia and first ischaemic stroke: a systematic review. Arch Dis Child. 2005;90: 402-405.
119. Vossen CY, Walker ID, Svensson P, Souto JC, Scharrer I, Preston FE, Palaretti G, Pabinger I, van der Meer FJ, Makris M, Fontcuberta J, Conard J, Rosendaal FR. Recurrence rate after first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol. 2005;25:1992-1997.
120. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica. 2002;87:1095-1108.
121. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism: a prospective cohort study in 1,626 patients. Haematologica. 2007;92: 199-205.
122. González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, Lozano F, San Miguel J. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. Blood Coagul Fibrinol. 2006;17:23-28.
123. De Stefano V, Simioni P, Rossi E, Tormene D, Za T, Pagnan A, Leone G. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C. and protein S. Haematologica. 2006;91:695-698.
124. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med. 2006;166:729-736.
125. Büller H, Agnelli G, Hull RD, Hyres TM, Prins M, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:S401-S428.